1s18: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /> <applet load="1s18" size="450" color="white" frame="true" align="right" spinBox="true" caption="1s18, resolution 1.70Å" /> '''Structure and prote...
 
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:1s18.gif|left|200px]]<br />
[[Image:1s18.gif|left|200px]]<br /><applet load="1s18" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="1s18" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="1s18, resolution 1.70&Aring;" />
caption="1s18, resolution 1.70&Aring;" />
'''Structure and protein design of human apyrase'''<br />
'''Structure and protein design of human apyrase'''<br />


==Overview==
==Overview==
Hematophagous arthropods secrete a salivary apyrase that inhibits platelet, activation by catabolizing ADP released from damaged tissues and blood, cells. We report the X-ray crystal structures of a human enzyme of the, soluble apyrase family in its apo state and bound to a substrate analog., The structures reveal a nucleotide binding domain comprising a five-blade, beta propeller, binding determinants of the substrate and the active site, and an unusual calcium binding site with a potential regulatory function., Using a comparative structural biology approach, we were able to redesign, the human apyrase so as to enhance its ADPase activity by more than, 100-fold. The engineered enzyme is a potent inhibitor of platelet, aggregation and may serve as the basis for the development of a new class, of antithrombotic agents.
Hematophagous arthropods secrete a salivary apyrase that inhibits platelet activation by catabolizing ADP released from damaged tissues and blood cells. We report the X-ray crystal structures of a human enzyme of the soluble apyrase family in its apo state and bound to a substrate analog. The structures reveal a nucleotide binding domain comprising a five-blade beta propeller, binding determinants of the substrate and the active site, and an unusual calcium binding site with a potential regulatory function. Using a comparative structural biology approach, we were able to redesign the human apyrase so as to enhance its ADPase activity by more than 100-fold. The engineered enzyme is a potent inhibitor of platelet aggregation and may serve as the basis for the development of a new class of antithrombotic agents.


==About this Structure==
==About this Structure==
1S18 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with CA, ACT and TRS as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Apyrase Apyrase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.6.1.5 3.6.1.5] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1S18 OCA].  
1S18 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=CA:'>CA</scene>, <scene name='pdbligand=ACT:'>ACT</scene> and <scene name='pdbligand=TRS:'>TRS</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Apyrase Apyrase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.6.1.5 3.6.1.5] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1S18 OCA].  


==Reference==
==Reference==
Line 19: Line 18:
[[Category: Liu, J.]]
[[Category: Liu, J.]]
[[Category: Lu, M.]]
[[Category: Lu, M.]]
[[Category: Smith, T.M.]]
[[Category: Smith, T M.]]
[[Category: ACT]]
[[Category: ACT]]
[[Category: CA]]
[[Category: CA]]
Line 28: Line 27:
[[Category: nucleotide-binding motif]]
[[Category: nucleotide-binding motif]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 19:09:07 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:56:48 2008''